<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>04260595531679</udiDi>
    <basicUdiDi>B-04260595531679</basicUdiDi>
    <tradeName>ocular®</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41067400L</reference>
    <placedOnMarketCountry>Portugal</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:53:14.912Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595530801</udiDi>
    <basicUdiDi>B-04260595530801</basicUdiDi>
    <tradeName>alins</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>41096600L</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:51:39.683Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595530399</udiDi>
    <basicUdiDi>B-04260595530399</basicUdiDi>
    <tradeName>OCUsalin® 5% UD</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>42010300L</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:51:14.080Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595530382</udiDi>
    <basicUdiDi>B-04260595530382</basicUdiDi>
    <tradeName>OCUsalin® 5% UD</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>42010200L</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:51:12.340Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260595530375</udiDi>
    <basicUdiDi>B-04260595530375</basicUdiDi>
    <tradeName>OCUsalin® 5% OSD</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>42012000L</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:51:11.386Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-DE-MF-000006543-30064SS</udiDi>
    <basicUdiDi>B-DE-MF-000006543-30064SS</basicUdiDi>
    <tradeName>medEctoin® Tag &amp; Nacht Intensiv Augengel 2%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>bitop AG</manufacturerName>
    <manufacturerSrn>DE-MF-000006543</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>30064</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-16T00:03:52.769Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-DE-MF-000006543-30062SN</udiDi>
    <basicUdiDi>B-DE-MF-000006543-30062SN</basicUdiDi>
    <tradeName>medEctoin® Eye Drops Allergy &amp; Inflammation</tradeName>
    <deviceName></deviceName>
    <manufacturerName>bitop AG</manufacturerName>
    <manufacturerSrn>DE-MF-000006543</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>30062</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-16T00:03:50.568Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-DE-MF-000006543-30058SX</udiDi>
    <basicUdiDi>B-DE-MF-000006543-30058SX</basicUdiDi>
    <tradeName>Ectoin® Allergy Eye Drops 2%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>bitop AG</manufacturerName>
    <manufacturerSrn>DE-MF-000006543</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>30058</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-16T00:03:46.174Z</lastUpdated>
  </row>
  <row>
    <udiDi>08717185943016</udiDi>
    <basicUdiDi>871921464Q020302996A</basicUdiDi>
    <tradeName>Optiview</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Ote Pharma Sol B.V.</manufacturerName>
    <manufacturerSrn>NL-MF-000010802</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T14:49:35.065Z</lastUpdated>
  </row>
</eudamedExport>